Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 204,920 | 147,435 | 94,640 | 266,956 | 304,487 |
| Marketable Securities | 241,057 | 373,271 | 445,651 | 289,962 | 273,281 |
| Receivables | 63,482 | 65,344 | 61,668 | 51,820 | 57,390 |
| Inventories | 7,009 | 7,881 | 14,336 | 10,786 | 10,311 |
| TOTAL | $542,223 | $617,823 | $640,917 | $645,730 | $673,984 |
| Non-Current Assets | |||||
| PPE Net | 7,531 | 8,047 | 8,581 | 9,197 | 9,757 |
| Intangibles | 0 | 0 | 0 | 369 | 738 |
| Other Non-Current Assets | 74,497 | 74,252 | 68,175 | 69,133 | 70,694 |
| TOTAL | $82,028 | $82,299 | $76,756 | $78,699 | $81,189 |
| Total Assets | $624,251 | $700,122 | $717,673 | $724,429 | $755,173 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,768 | 6,876 | 7,722 | 9,065 | 8,849 |
| Accrued Expenses | 108,835 | 89,192 | 80,496 | 86,263 | 100,524 |
| TOTAL | $119,603 | $96,068 | $88,218 | $95,328 | $109,373 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,851 | 63,160 | 62,500 | 64,263 | 64,194 |
| TOTAL | $59,851 | $63,160 | $62,500 | $64,263 | $64,194 |
| Total Liabilities | $179,454 | $159,228 | $150,718 | $159,591 | $173,567 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 161,429 | 161,204 | 160,756 | 160,643 | 160,179 |
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -2,266,632 | -2,153,576 | -2,110,482 | -2,096,025 | -2,052,154 |
| Other shareholders' equity | -612 | -192 | -1 | 38 | 34 |
| TOTAL | $444,797 | $540,894 | $566,955 | $564,838 | $581,606 |
| Total Liabilities And Equity | $624,251 | $700,122 | $717,673 | $724,429 | $755,173 |